Since these mutations generally do not occur in operated patients and those persisting after valvular replacement are neutral (neither beneficial nor deleterious), the involvement of MT-CYB mutations in ARF complications can be considered (RHD). This evidence concerns the gene MCAT and rheumatic fever.